Media Room

2020/12/15 Capital participation in Genex Inc.

We are pleased to report that the Funds, to which we provide investment-related services (*1) is completing the capital participation in Genex Inc. (head office: Nagoya-shi, Aichi; CEO: Kengo Suruga; URL: ttps://www.gnx.co.jp/; "Genex").

Genex was founded by Mr. Kengo Suruga, President and Representative Director, in 2009. Genex specializes in generic drugs within pharmaceutical product wholesale business sector and is ranked top among those independent from pharmaceutical manufacturer groups, by establishing proprietary business model with efficient sales and logistics functions.

We believe Genex will play much important roles and its growth will serve solving the challenges in Japanese society where generic pharmaceutical products usage is destined to grow to cope with the increasing national medical expenses.

We will seek further growth of Genex together with Mr. Kengo Suruga and Medical System Network Co., Ltd, its existing shareholders.


(* 1) J-STAR Co., Ltd. provides investment-related services including investigation, investment opportunity introduction, or support for portfolio companies, to the Funds (J-STAR No.4 A, LP, etc.), respectively. 

Capital participation in Genex Inc.(PDF:127.4 KB)